The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
The new powder flow tester can characterize powder flow properties, offering valuable insight for pharmaceutical processing and formulation
Molnupiravir is an orally administered form of a potent ribonucleoside analog that inhibits the replication of SARS-CoV-2
Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively
Subscribe To Our Newsletter & Stay Updated
